All News #Library
Rare Diseases
CANTEX Pharma Receives FDA Orphan Drug Designation for Azeliragon
09 Dec 2024 //
PR NEWSWIRE
CANTEX Gets FDA Orphan Drug For Azeliragon In Pancreatic Cancer
20 May 2024 //
PR NEWSWIRE

Market Place
Sourcing Support